New forms and resources for IRB submissions on the Pearl IRB website

We are pleased to announce our recent updates to the Pearl IRB website. In the Resources section, you will find new and revised forms to serve you in the IRB submission process. Some of these changes include: Updated submission guide and policies, which we suggest all...

FDA releases final guidance on transfer of IRB oversight

FDA has issued final guidance concerning the transfer of clinical studies between IRBs. According to Zachary Brennan on www.outsourcing-pharma.com, FDA says the transfer process “should be accomplished in a way that assures continuous IRB oversight with no lapse in...

Important Clinical Trial Facts

Cameron from Total Biopharma introduces an interesting artical about how clinical trials are being designed and executed to fit the changing needs of the industry.  With costs and complexity increasing in clinical reseach, Total Biopharma offers their own A-Z...

Article from Pearl IRB staff featured in SCRS InSite magazine

Check out this article (login registration is required) entitled “What could proposed changes to the Common Rule mean to sites, sponsors and IRBs” published in the Q2 2013 edition of the Society for Clinical Research Sites’ online journal, InSite. ...